American College of Cardiology

NOVEMBER 19, 2024

What is the impact of intraoperative His bundle (HB) mapping during complex biventricular congenital heart disease (CHD) repair on postoperative atrioventricular block requiring pacemaker (AVB/PM)?

Congenital Heart Disease 49

Congenital Heart Disease Congenital Heart Disease Pacemaker 49

HeartRhythm

OCTOBER 15, 2023

Ivabradine is an anti-arrhythmic agent that reduces the heart rate through inhibition of the pacemaker current of the sinoatrial node. It has been used to treat both inappropriate sinus tachycardia and sinus tachycardia related to heart failure in children and adults.

Congenital Heart Disease 40

Congenital Heart Disease Tachycardia Congenital Heart Disease 40

Conquering CHD

MARCH 7, 2024

This can be an especially trying time in the life of an adolescent with congenital heart disease, especially as they are undergoing the major transition of leaving the nest and going off to college, joining the workforce, or just moving far from home.

Congenital Heart Disease 98

Congenital Heart Disease Congenital Pediatrics Heart Disease 98

Journal of Cardiovascular Electrophysiology

MARCH 27, 2024

Abstract Introduction Pacemaker implantation can be challenging in patients with congenital heart disease. Methods and Results In a patient with Ebstein disease and symptomatic sinus node dysfunction, despite multiple attempts, the Micra® pacemaker could not be implanted in the severely dilated right ventricle.

Pacemaker 49

Pacemaker Congenital Heart Disease Congenital Heart Disease 49

Journal of Cardiothoracic Surgery

JULY 19, 2024

High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of.

Congenital Heart Disease 40

Congenital Heart Disease Pediatrics Pacemaker Congenital 40

Journal of Cardiovascular Electrophysiology

JANUARY 11, 2024

Abstract Introduction Patients with congenital heart disease are at increased risk for requiring cardiac pacing during their lifetime. Due to atrial and ventricular pacing dependence, a comprehensive congenital care team concluded the need for lead extraction and replacement of pacemaker via leadless peacemaking device.

Pacemaker 40

Pacemaker Congenital Heart Disease Congenital Anatomy 40

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Three patients developed symptomatic sinus node dysfunction at 18, 25, and 38 days and received permanent pacemakers. months (IQR: 13.13–111.87),

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Pacemaker 59